-
341
-
342
Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1
Published 2025-01-01Subjects: Get full text
Article -
343
Long-term sublingual bacterial immunotherapy prevents ear, nose and throat infections: A real-life study
Published 2025-01-01“…Methods: Patients received sublingual bacterial immunotherapy for 12 months and were followed for 24 months. …”
Get full text
Article -
344
Shrimp allergen extract immunotherapy induces prolonged immune tolerance in a gastro-food allergy mouse model.
Published 2024-01-01“…This study aimed to determine the effectiveness of SAE in inducing immunological tolerance in a gastro-food allergy mouse model. For the immunotherapy evaluation, mice (n = 24) were intraperitoneally (i.p.) sensitized with 1 mg alum and 100 μg SAE in PBS on days 0, 7, and 14 and randomly divided into four groups of six: a negative control (NC) and high- to low-dose immunotherapy (HI, MI, and LI). …”
Get full text
Article -
345
Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy
Published 2025-04-01“…Low immunogenicity and immunosuppressive tumor microenvironment (TME) are two pivotal factors restricting tumor immunotherapy. Photodynamic therapy (PDT) directly destroys cancer cells by producing reactive oxygen species (ROS), and enhances the immunogenicity of ''cold'' tumors by inducing immunogenic cell death (ICD), thereby promoting T cell development against tumors. …”
Get full text
Article -
346
A Golgi apparatus‑related subtype and risk signature predicts prognosis and evaluates immunotherapy response in gastric cancer
Published 2025-01-01Subjects: Get full text
Article -
347
Efficacy and safety of immunotherapy for head and neck squamous cell carcinoma: a meta-analysis of randomized clinical trials
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
348
-
349
Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
350
Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes
Published 2015-01-01“…The purpose of this study was to determine the cellular effectors of both the adoptively transferred cells and the tumor-bearing host that participate in the antitumor response to adoptive immunotherapy using culture-activated tumor-draining lymph nodes (TDLNs). …”
Get full text
Article -
351
-
352
-
353
Multimodal data deep learning method for predicting symptomatic pneumonitis caused by lung cancer radiotherapy combined with immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
354
A Turbo‐Charging System‐Like Contrast Agent for MRI‐Guided STING Pathway‐Activated Cancer Immunotherapy
Published 2025-01-01Subjects: “…cancer immunotherapy…”
Get full text
Article -
355
Reaction-Diffusion on a Spatial Mathematical Model of Cancer Immunotherapy with Effector Cells and IL-2 Compounds’ Interactions
Published 2021-01-01“…Immunotherapy is one of the future treatments applicable in most cases of cancer including malignant cancer. …”
Get full text
Article -
356
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
Published 2025-02-01Subjects: Get full text
Article -
357
-
358
-
359
Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
360
Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
Published 2025-01-01“…Abstract The efficacy of cancer immunotherapy relies on a sufficient amount of functional immune cells. …”
Get full text
Article